RVMD
Revolution Medicines, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Revolution Medicines, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Revolution Medicines, Inc.
191.49
Linked news
700 managers report $41.1B of Revolution Medicines on form 13F for the quarter ended Jun 30 '26. 42 of them hold 80% of it; BlackRock is largest at 6.24%.
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $2.6B | 6.24% | +22.15% | |
| 2 | Farallon Capital ManagementFarallon | $2.5B | 6.17% | −0.40% | |
| 3 | FMRFMR | $2.3B | 5.56% | +44.14% | |
| 4 | Baker Bros. AdvisorsBaker Bros. | $2.1B | 5.21% | +19.76% | |
| 5 | Darwin Global ManagementDarwin Global | $2.0B | 4.98% | +380.77% | |
| 6 | Jupiter TopcoJupiter Topco | $2.0B | 4.89% | — | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $1.7B | 4.14% | +8.69% | |
| 8 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $1.6B | 3.78% | +10.56% | |
| 9 | Nextech InvestNextech Invest | $1.4B | 3.46% | 0.00% | |
| 10 | Paradigm Biocapital AdvisorsParadigm Biocapital | $1.2B | 2.90% | −4.42% | |
| 11 | UBS GroupUBS | $1.0B | 2.49% | +24.15% | |
| 12 | State StreetState Streetindex-like | $917.1M | 2.23% | +11.23% | |
| 13 | Capital World InvestorsCapital World Investors | $750.7M | 1.83% | new | |
| 14 | Geode Capital ManagementGeodeindex-like | $736.8M | 1.79% | +18.11% | |
| 15 | Wellington Management GroupWellington | $719.8M | 1.75% | −36.24% | |
| 16 | JPMorgan ChaseJPMorgan Chase | $636.9M | 1.55% | +994.27% | |
| 17 | BVFBVF | $555.3M | 1.35% | +3.79% | |
| 18 | AlphabetAlphabet | $551.8M | 1.34% | −10.51% | |
| 19 | Casdin CapitalCasdin Capital | $482.7M | 1.17% | 0.00% | |
| 20 | Deerfield ManagementDeerfield | $448.0M | 1.09% | +4.14% | |
| 21 | T. Rowe Price AssociatesT. Rowe Price | $447.7M | 1.09% | −26.05% | |
| 22 | venBio Select AdvisorvenBio Select Advisor | $430.2M | 1.05% | −2.02% | |
| 23 | Caligan PartnersCaligan Partners | $414.6M | 1.01% | +17.64% | |
| 24 | Norges BankNorges Bankindex-like | $404.1M | 0.98% | — | |
| 25 | Goldman Sachs GroupGoldman Sachs | $399.5M | 0.97% | −2.40% |
Fund move
No thesis.
Expected move
Inputsstraddle ±10.4%
spot 191.31exp Nov 20ATM strike 190ATM straddle 23.30IV 64%